Author
Listed:
- Alasdair T. M. Hubbard
(Liverpool School of Tropical Medicine, Pembroke Place)
- Jenifer Mason
(Liverpool University Hospital Foundation Trust)
- Paul Roberts
(Liverpool University Hospital Foundation Trust
University of Wolverhampton, Wulfruna Building MA)
- Christopher M. Parry
(Alder Hey Children’s NHS Foundation Trust
University of Liverpool
Clinical Sciences, Liverpool School of Tropical Medicine, Pembroke Place
University of Nagasaki)
- Caroline Corless
(Liverpool University Hospital Foundation Trust)
- Jon Aartsen
(Liverpool University Hospital Foundation Trust)
- Alex Howard
(Liverpool University Hospital Foundation Trust)
- Issra Bulgasim
(Liverpool School of Tropical Medicine, Pembroke Place)
- Alice J. Fraser
(Liverpool School of Tropical Medicine, Pembroke Place)
- Emily R. Adams
(Liverpool School of Tropical Medicine, Pembroke Place)
- Adam P. Roberts
(Liverpool School of Tropical Medicine, Pembroke Place)
- Thomas Edwards
(Liverpool School of Tropical Medicine, Pembroke Place)
Abstract
A phenotype of Escherichia coli and Klebsiella pneumoniae, resistant to piperacillin/tazobactam (TZP) but susceptible to carbapenems and 3rd generation cephalosporins, has emerged. The resistance mechanism associated with this phenotype has been identified as hyperproduction of the β-lactamase TEM. However, the mechanism of hyperproduction due to gene amplification is not well understood. Here, we report a mechanism of gene amplification due to a translocatable unit (TU) excising from an IS26-flanked pseudo-compound transposon, PTn6762, which harbours blaTEM-1B. The TU re-inserts into the chromosome adjacent to IS26 and forms a tandem array of TUs, which increases the copy number of blaTEM-1B, leading to TEM-1B hyperproduction and TZP resistance. Despite a significant increase in blaTEM-1B copy number, the TZP-resistant isolate does not incur a fitness cost compared to the TZP-susceptible ancestor. This mechanism of amplification of blaTEM-1B is an important consideration when using genomic data to predict susceptibility to TZP.
Suggested Citation
Alasdair T. M. Hubbard & Jenifer Mason & Paul Roberts & Christopher M. Parry & Caroline Corless & Jon Aartsen & Alex Howard & Issra Bulgasim & Alice J. Fraser & Emily R. Adams & Adam P. Roberts & Thom, 2020.
"Piperacillin/tazobactam resistance in a clinical isolate of Escherichia coli due to IS26-mediated amplification of blaTEM-1B,"
Nature Communications, Nature, vol. 11(1), pages 1-9, December.
Handle:
RePEc:nat:natcom:v:11:y:2020:i:1:d:10.1038_s41467-020-18668-2
DOI: 10.1038/s41467-020-18668-2
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:11:y:2020:i:1:d:10.1038_s41467-020-18668-2. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.